PTC Therapeutics
PTCT
PTCT
166 hedge funds and large institutions have $1.45B invested in PTC Therapeutics in 2018 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 57 increasing their positions, 42 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4% more call options, than puts
Call options by funds: $24.9M | Put options by funds: $23.9M
9.79% less ownership
Funds ownership: 102.12% → 92.33% (-9.8%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
166
Holding in Top 10
6
Calls
$24.9M
Puts
$23.9M
Top Buyers
| 1 | +$77.4M | |
| 2 | +$35.4M | |
| 3 | +$22.5M | |
| 4 |
Goldman Sachs
New York
|
+$19.1M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$16M |
Top Sellers
| 1 | -$122M | |
| 2 | -$23.6M | |
| 3 | -$19.7M | |
| 4 |
Citigroup
New York
|
-$15.9M |
| 5 |
Two Sigma Investments
New York
|
-$14M |